版本:
中国

BRIEF-Lannett announces FDA approval for levocetirizine dihydrochloride oral solution, 2.5 mg/5 ml

May 16 Lannett Company Inc

* Lannett announces approval for levocetirizine dihydrochloride oral solution, 2.5 mg/5 ml (0.5 mg/ml)

* Lannett says levocetirizine dihydrochloride oral solution will be manufactured in Carmel, New York by Silarx Pharmaceuticals Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐